These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5638146)

  • 1. Urinary metabolites in Parkinson's disease.
    Kuehl FA; Vandenheuvel WJ; Ormond RE
    Nature; 1968 Jan; 217(5124):136-8. PubMed ID: 5638146
    [No Abstract]   [Full Text] [Related]  

  • 2. The identity of the so-called pink spot in schizophrenia and Parkinson's disease.
    Heslinga FJ; van Tilburg W; Stam FC
    Psychiatr Neurol Neurochir; 1970; 73(3):157-64. PubMed ID: 5310324
    [No Abstract]   [Full Text] [Related]  

  • 3. Identity of a urinary "pink spot" in schizophrenia and Parkinson's disease.
    Boulton AA; Pollitt RJ; Majer JR
    Nature; 1967 Jul; 215(5097):132-4. PubMed ID: 6049100
    [No Abstract]   [Full Text] [Related]  

  • 4. Schizophrenia and pink spot.
    Stam FC; Heslinga FJ; van Tilburg W
    Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"].
    Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A
    Encephale; 1969; 58(4):360-76. PubMed ID: 5378191
    [No Abstract]   [Full Text] [Related]  

  • 6. A biochemical study of early infantile austism.
    Himwich HE; Jenkins RL; Fujimori M; Narasimhachari N; Ebersole M
    J Autism Child Schizophr; 1972; 2(2):114-26. PubMed ID: 5068665
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary amines in chronic schizophrenia.
    Perry TL; Hansen S; MacDougall L
    Nature; 1966 Oct; 212(5058):146-8. PubMed ID: 5339580
    [No Abstract]   [Full Text] [Related]  

  • 8. Methylated psychotogens in the urine of psychiatric patients.
    Kanabus P; Krysa G; Matsumoto H; Stencka K
    Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608
    [No Abstract]   [Full Text] [Related]  

  • 9. Diminution of phenethylamine in the urine of Parkinson patients.
    Heller B; Fischer E
    Arzneimittelforschung; 1973 Jun; 23(6):884-6. PubMed ID: 4740778
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary excretion of 3,4-dimethoxyphenylethylamine in Parkinson's disease.
    Rinne UK; Sonninen V
    Nature; 1967 Nov; 216(5114):489. PubMed ID: 6057254
    [No Abstract]   [Full Text] [Related]  

  • 11. Aromatic amines and Parkinson's disease.
    Smith I; Kellow AH
    Nature; 1969 Mar; 221(5187):1261. PubMed ID: 5773846
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-phenylethylamine in human urine.
    Fischer E; Heller B; Miró AH
    Arzneimittelforschung; 1968 Nov; 18(11):1486. PubMed ID: 5755919
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced tyramine conjugation in Parkinson's disease.
    Carter SM; Youdim MB; Sandler M; Hunter KR; Stern GM
    Clin Chim Acta; 1974 Mar; 51(3):327-9. PubMed ID: 4826525
    [No Abstract]   [Full Text] [Related]  

  • 14. Some observations concerning the "pink spot" reacting substances in urine.
    Watt JA; Ashcroft GW; Daly RJ; Smythies JR
    Acta Psychiatr Scand; 1970; 46(4):374-90. PubMed ID: 5502783
    [No Abstract]   [Full Text] [Related]  

  • 15. 3,4-dimethoxyphenylethylamine in schizophrenia.
    Williams CH; Gibson JG; McCormick WO
    Nature; 1966 Sep; 211(5054):1195. PubMed ID: 6008085
    [No Abstract]   [Full Text] [Related]  

  • 16. [Presence of N-methylated and N-acetylated indolamines in urine from patients with schizophrenia and from normal individuals].
    Faurbye A; Pind K
    Ugeskr Laeger; 1971 Jul; 133(28):1356-8. PubMed ID: 5566986
    [No Abstract]   [Full Text] [Related]  

  • 17. Mauve spot and schizophrenia.
    Ellman GL; Jones RT; Rychert RC
    Am J Psychiatry; 1968 Dec; 125(6):849-51. PubMed ID: 5698458
    [No Abstract]   [Full Text] [Related]  

  • 18. The pink spot: a red herring?
    Lancet; 1966 Oct; 2(7468):848-9. PubMed ID: 4162179
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of L-dopa therapy on urinary p-tyramine excretion and EEG changes in Parkinson's disease.
    Boulton AA; Marjerrison GL
    Nature; 1972 Mar; 236(5341):76-8. PubMed ID: 4553458
    [No Abstract]   [Full Text] [Related]  

  • 20. Separation and quantitation of some urinary arylalkylamines.
    Slingsby JM; Boulton AA
    J Chromatogr; 1976 Jul; 123(1):51-6. PubMed ID: 950359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.